메뉴 건너뛰기




Volumn 13, Issue 1, 2014, Pages

Trends in drug resistance codons in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Kenyan parasites from 2008 to 2012

Author keywords

Malaria; Plasmodium falciparum dihydrofolate reductase; Plasmodium falciparum dihydropteroate synthase

Indexed keywords

PYRIMETHAMINE PLUS SULFADOXINE; ANTIMALARIAL AGENT; DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE;

EID: 84903420058     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-13-250     Document Type: Article
Times cited : (25)

References (34)
  • 2
    • 0033775025 scopus 로고    scopus 로고
    • The changing in vitro susceptibility pattern to pyrimethamine/sulfadoxine in Plasmodium falciparum field isolates from Kilifi, Kenya
    • 11037785
    • The changing in vitro susceptibility pattern to pyrimethamine/sulfadoxine in Plasmodium falciparum field isolates from Kilifi, Kenya. Mberu EK, Mosobo MK, Nzila AM, Kokwaro GO, Sibley CH, Watkins WM, Am J Trop Med Hyg 2000 62 396 401 11037785
    • (2000) Am J Trop Med Hyg , vol.62 , pp. 396-401
    • Mberu, E.K.1    Mosobo, M.K.2    Nzila, A.M.3    Kokwaro, G.O.4    Sibley, C.H.5    Watkins, W.M.6
  • 3
    • 34250307500 scopus 로고    scopus 로고
    • The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya
    • DOI 10.1186/1475-2875-6-72
    • The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya. Amin AA, Zurovac D, Kangwana BB, Greenfield J, Otieno DN, Akhwale WS, Snow RW, Malar J 2007 6 72 10.1186/1475-2875-6-72 17535417 (Pubitemid 46919082)
    • (2007) Malaria Journal , vol.6 , pp. 72
    • Amin, A.A.1    Zurovac, D.2    Kangwana, B.B.3    Greenfield, J.4    Otieno, D.N.5    Akhwale, W.S.6    Snow, R.W.7
  • 4
    • 34249889049 scopus 로고    scopus 로고
    • Safety and toxicity of sulfadoxine/pyrimethamine: Implications for malaria prevention in pregnancy using intermittent preventive treatment
    • DOI 10.2165/00002018-200730060-00003
    • Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment. Peters PJ, Thigpen MC, Parise ME, Newman RD, Drug Saf 2007 30 481 501 10.2165/00002018-200730060-00003 17536875 (Pubitemid 46873074)
    • (2007) Drug Safety , vol.30 , Issue.6 , pp. 481-501
    • Peters, P.J.1    Thigpen, M.C.2    Parise, M.E.3    Newman, R.D.4
  • 6
    • 77956487852 scopus 로고    scopus 로고
    • Anti-folate drug resistance in Africa: Meta-analysis of reported dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant genotype frequencies in African Plasmodium falciparum parasite populations
    • 10.1186/1475-2875-9-247 20799995
    • Anti-folate drug resistance in Africa: meta-analysis of reported dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant genotype frequencies in African Plasmodium falciparum parasite populations. Sridaran S, McClintock SK, Syphard LM, Herman KM, Barnwell JW, Udhayakumar V, Malar J 2010 9 247 10.1186/1475-2875-9-247 20799995
    • (2010) Malar J , vol.9 , pp. 247
    • Sridaran, S.1    McClintock, S.K.2    Syphard, L.M.3    Herman, K.M.4    Barnwell, J.W.5    Udhayakumar, V.6
  • 8
    • 0000841123 scopus 로고
    • Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria
    • DOI 10.1073/pnas.85.23.9114
    • Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Peterson DS, Wallikier D, Wellems TE, Proc Natl Acad Sci U S A 1988 85 9114 9118 10.1073/pnas.85.23.9114 2904149 (Pubitemid 19001850)
    • (1988) Proceedings of the National Academy of Sciences of the United States of America , vol.85 , Issue.23 , pp. 9114-9118
    • Peterson, D.S.1    Walliker, D.2    Wellems, T.E.3
  • 10
    • 0031963057 scopus 로고    scopus 로고
    • Kenyan Plasmodium falciparum field isolates: Correlation between pyrimethamine and chlorcycloguanil activity in vitro and point mutations in the dihydrofolate reductase domain
    • Kenyan Plasmodium falciparum field isolates: correlation between pyrimethamine and chlorcycloguanil activity in vitro and point mutations in the dihydrofolate reductase domain. Nzila-Mounda A, Mberu EK, Sibley CH, Plowe CV, Winstanley PA, Watkins WM, Antimicrob Agents Chemother 1998 42 164 169 9449279 (Pubitemid 28053345)
    • (1998) Antimicrobial Agents and Chemotherapy , vol.42 , Issue.1 , pp. 164-169
    • Nzila-Mounda, A.1    Mberu, E.K.2    Sibley, C.H.3    Plowe, C.V.4    Winstanley, P.A.5    Watkins, W.M.6
  • 12
    • 0025263958 scopus 로고
    • Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance
    • 10.1073/pnas.87.8.3014 2183221
    • Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. Foote SJ, Galatis D, Cowman AF, Proc Natl Acad Sci U S A 1990 87 3014 3017 10.1073/pnas.87.8.3014 2183221
    • (1990) Proc Natl Acad Sci U S A , vol.87 , pp. 3014-3017
    • Foote, S.J.1    Galatis, D.2    Cowman, A.F.3
  • 15
    • 0032527779 scopus 로고    scopus 로고
    • Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria
    • DOI 10.1093/emboj/17.14.3807
    • Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria. Triglia T, Wang P, Sims PF, Hyde JE, Cowman AF, EMBO J 1998 17 3807 3815 10.1093/emboj/17.14.3807 9669998 (Pubitemid 28333967)
    • (1998) EMBO Journal , vol.17 , Issue.14 , pp. 3807-3815
    • Triglia, T.1    Wang, P.2    Sims, P.F.G.3    Hyde, J.E.4    Cowman, A.F.5
  • 16
    • 0037794109 scopus 로고    scopus 로고
    • Dihydrofolate reductase and dihydropteroate synthase genotypes associated with in vitro resistance of Plasmodium falciparum to pyrimethamine, trimethoprim, sulfadoxine, and sulfamethoxazole
    • Dihydrofolate reductase and dihydropteroate synthase genotypes associated with in vitro resistance of Plasmodium falciparum to pyrimethamine, trimethoprim, sulfadoxine, and sulfamethoxazole. Khalil I, Ronn AM, Alifrangis M, Gabar HA, Satti GM, Bygbjerg IC, Am J Trop Med Hyg 2003 68 586 589 12812351 (Pubitemid 38240499)
    • (2003) American Journal of Tropical Medicine and Hygiene , vol.68 , Issue.5 , pp. 586-589
    • Khalil, I.1    Ronn, A.M.2    Alifrangis, M.3    Gabar, H.A.4    Satti, G.M.H.5    Bygbjerg, I.C.6
  • 18
    • 78549234725 scopus 로고    scopus 로고
    • Increased prevalence of the pfdhfr/phdhps quintuple mutant and rapid emergence of pfdhps resistance mutations at codons 581 and 613 in Kisumu, Kenya
    • 10.1186/1475-2875-9-338 21106088
    • Increased prevalence of the pfdhfr/phdhps quintuple mutant and rapid emergence of pfdhps resistance mutations at codons 581 and 613 in Kisumu, Kenya. Spalding MD, Eyase FL, Akala HM, Bedno SA, Prigge ST, Coldren RL, Moss WJ, Waters NC, Malar J 2010 9 338 10.1186/1475-2875-9-338 21106088
    • (2010) Malar J , vol.9 , pp. 338
    • Spalding, M.D.1    Eyase, F.L.2    Akala, H.M.3    Bedno, S.A.4    Prigge, S.T.5    Coldren, R.L.6    Moss, W.J.7    Waters, N.C.8
  • 20
    • 0031757031 scopus 로고    scopus 로고
    • Reemergence of epidemic malaria in the highlands of western Kenya
    • Reemergence of epidemic malaria in the highlands of western Kenya. Malakooti MA, Biomndo K, Shanks GD, Emerg Infect Dis 1998 4 671 676 10.3201/eid0404.980422 9866748 (Pubitemid 28553696)
    • (1998) Emerging Infectious Diseases , vol.4 , Issue.4 , pp. 671-676
    • Malakooti, M.A.1    Biomndo, K.2    Shanks, G.D.3
  • 21
    • 77957913694 scopus 로고    scopus 로고
    • Changing malaria intervention coverage, transmission and hospitalization in Kenya
    • 10.1186/1475-2875-9-285 20946689
    • Changing malaria intervention coverage, transmission and hospitalization in Kenya. Emelda AO, Victor AA, Abdisalan MN, Robert WS, Malar J 2010 9 285 10.1186/1475-2875-9-285 20946689
    • (2010) Malar J , vol.9 , pp. 285
    • Emelda, A.O.1    Victor, A.A.2    Abdisalan, M.N.3    Robert, W.S.4
  • 28
    • 0037396367 scopus 로고    scopus 로고
    • The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum
    • DOI 10.1046/j.1472-8206.2003.00164.x
    • The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum. Le Bras J, Durand R, Fundam Clin Pharmacol 2003 17 147 153 10.1046/j.1472-8206.2003.00164.x 12667224 (Pubitemid 36513205)
    • (2003) Fundamental and Clinical Pharmacology , vol.17 , Issue.2 , pp. 147-153
    • Le Bras, J.1    Durand, R.2
  • 30
    • 0030801206 scopus 로고    scopus 로고
    • Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins
    • DOI 10.1016/S0166-6851(97)00114-X, PII S016668519700114X
    • Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins. Wang P, Lee CS, Bayoumi R, Djimde A, Doumbo O, Swedberg G, Dao LD, Mshinda H, Tanner M, Watkins WM, Sims PF, Hyde JE, Mol Biochem Parasitol 1997 89 161 177 10.1016/S0166-6851(97)00114-X 9364963 (Pubitemid 27435090)
    • (1997) Molecular and Biochemical Parasitology , vol.89 , Issue.2 , pp. 161-177
    • Wang, P.1    Lee, C.-S.2    Bayoumi, R.3    Djimde, A.4    Doumbo, O.5    Swedberg, G.6    Dao, L.D.7    Mshinda, H.8    Tanner, M.9    Watkins, W.M.10    Sims, P.F.G.11    Hyde, J.E.12
  • 31
    • 36049010956 scopus 로고    scopus 로고
    • The implication of dihydrofolate reductase and dihydropteroate synthetase gene mutations in modification of Plasmodium falciparum characteristics
    • DOI 10.1186/1475-2875-6-108
    • The implication of dihydrofolate reductase and dihydropteroate synthetase gene mutations in modification of Plasmodium falciparum characteristics. Ishraga A-E, Michael A, Insaf K, Ib B, Emad M, Mustafa E, Hayder G, Malar J 2007 6 108 10.1186/1475-2875-6-108 17686173 (Pubitemid 350092571)
    • (2007) Malaria Journal , vol.6 , pp. 108
    • A-Elbasit, I.E.1    Alifrangis, M.2    Khalil, I.F.3    Bygbjerg, I.C.4    Masuadi, E.M.5    Elbashir, M.I.6    Giha, H.A.7
  • 32
    • 65349155111 scopus 로고    scopus 로고
    • Five-year surveillance of molecular markers of Plasmodium falciparum antimalarial drug resistance in Korogwe District, Tanzania: Accumulation of the 581G mutation in the P. Falciparum dihydropteroate synthase gene
    • 19346369
    • Five-year surveillance of molecular markers of Plasmodium falciparum antimalarial drug resistance in Korogwe District, Tanzania: accumulation of the 581G mutation in the P. falciparum dihydropteroate synthase gene. Alifrangis M, Lusingu JP, Mmbando B, Dalgaard MB, Vestergaard LS, Ishengoma D, Khalil IF, Theander TG, Lemnge MM, Bygbjerg IC, Am J Trop Med Hyg 2009 80 523 527 19346369
    • (2009) Am J Trop Med Hyg , vol.80 , pp. 523-527
    • Alifrangis, M.1    Lusingu, J.P.2    Mmbando, B.3    Dalgaard, M.B.4    Vestergaard, L.S.5    Ishengoma, D.6    Khalil, I.F.7    Theander, T.G.8    Lemnge, M.M.9    Bygbjerg, I.C.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.